My Companies
Notification
Account
Board approved fundraise via Rights Issue of up to Rs 50 Crore and increase in Authorised Share Capital from Rs 20 Crore to Rs 65 Crore. Resignation of two independent directors was noted.
Niraj Shah Acquires 6.44% Stake in Bacil Pharma via Open Market
Bacil Pharma Board Approves ₹50 Crore Fundraising via Equity Instruments
Bacil Pharma Non-Promoter Manubhai Shah Sells 2.75% Stake in Two Days
Bacil Pharma Non-Promoter Nikita Patel Sells 7.10% Stake in Two Days